A Highly Potent SARS-CoV-2 Blocking Lectin Protein-Reference-Cited by-同舟云学术

A Highly Potent SARS-CoV-2 Blocking Lectin Protein

Published:2022-04-15 Issue:7 Volume:8 Page:1253-1264
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Ahan Recep E.¹,Hanifehnezhad Alireza²,Kehribar Ebru Ş.¹,Oguzoglu Tuba C.²,Földes Katalin²,Özçelik Cemile E.¹,Filazi Nazlican²,Öztop Sıdıka³^ORCID,Palaz Fahreddin⁴^ORCID,Önder Sevgen⁵,Bozkurt Eray U.¹,Ergünay Koray⁶,Özkul Aykut²⁷,Şeker Urartu Özgür Şafak¹^ORCID

Affiliation:

1. UNAM-Institute of Materials Science and Nanotechnology, Bilkent University, Ankara 06800, Turkey

2. Faculty of Veterinary Medicine, Department of Virology, Ankara University, Ankara 06110, Turkey

3. Adana Dr. Turgut Noyan Medical and Research Center, Department of Immunology, Baskent University, Adana 01250, Turkey

4. Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey

5. Faculty of Medicine, Department of Medical Pathology, Hacettepe University, Ankara 06230, Turkey

6. Faculty of Medicine, Department of Medical Microbiology, Virology Unit, Hacettepe University, Ankara 06230, Turkey

7. Biotechnology Institute, Ankara University, Ankara 06135, Turkey

Funder

Türkiye Bilimsel ve Teknolojik Arastirma Kurumu

Ministry of Industry, and Technology of Turkey

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.2c00006

Reference58 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

2. A new coronavirus associated with human respiratory disease in China

3. A pneumonia outbreak associated with a new coronavirus of probable bat origin

4. dGhebreyesus, T. WHO Director-General’s opening remarks at the media briefing on COVID-19-2020. 2020.

5. Geographic and Genomic Distribution of SARS-CoV-2 Mutations

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus spike protein-based vaccines. Vaccine delivery systems;Medicine in Drug Discovery;2024-09

2. Lectins in oncology and virology: Mechanisms of anticancer activity and SARS-CoV-2 inhibition;International Journal of Biological Macromolecules;2024-08

3. Lectibodies as antivirals;Antiviral Research;2024-07

4. Variant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis;Journal of Neurochemistry;2024-04-20

5. Polysaccharides and Lectins: A Natural Complementary Approach against the SARS-CoV-2 Pandemic;Microbiology Research;2024-04-09